SCHEMBL15680239

SCHEMBL15680239

Cc1cn(C)c2cc(O)c(O)cc2c1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.40
SRC P12931 3/20 0.39
THRB P10828 2/20 0.37
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 2/20 0.37
HPGD P15428 2/20 0.37
HSD17B10 Q99714 2/20 0.37
CYP3A4 P08684 1/20 0.37
AKR1B1 P15121 1/20 0.37
MCL1 Q07820 1/20 0.37
MAOB P27338 1/20 0.33
DPP3 Q9NY33 1/20 0.33
GPR35 Q9HC97 1/20 0.33
NPC1 O15118 1/20 0.32
MAP3K5 Q99683 1/20 0.32
TYR P14679 1/20 0.32
GLA P06280 1/20 0.32
GAA P10253 1/20 0.32
CYP2C19 P33261 1/20 0.32
HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15680199 0.81 SRC (0.36) SRCTHRBKDM4EALDH1A1HPGD
SCHEMBL17191916 0.81 SCN9A (0.37) TP53SRCKDM4EALDH1A1HSD17B10
SCHEMBL19426037 0.79 SRC (0.44) SRCKDM4EALDH1A1HPGDHSD17B10
SCHEMBL15680215 0.77 SRC (0.46) SRCKDM4EALDH1A1HPGDHSD17B10
SCHEMBL15680209 0.77 SRC (0.36) SRCTHRBKDM4EALDH1A1HPGD
SCHEMBL9321255 0.77 LMNA (0.51) SRCKDM4EALDH1A1HPGDHSD17B10
SCHEMBL19426082 0.77 SRC (0.36) SRCKDM4EGPR35
SCHEMBL22014783 0.76 TP53 (0.51) TP53THRBNPC1KMT2A
SCHEMBL3077415 0.76 SRC (0.37) SRCALDH1A1GPR35
SCHEMBL15680175 0.75 KDM4E (0.38) SRCKDM4EALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170281532-A1 2 SUBSTITUTED CEPHEM COMPOUNDS GLAXO GROUP LIMITED (GB) 2017-10-05 US disclosed
US-20150299223-A1 2-SUBSTITUTED CEPHEM COMPOUNDS GLAXO GROUP LTD (GB) 2015-10-22 US disclosed
WO-2014068388-A1 2 SUBSTITUTED CEPHEM COMPOUNDS GLAXO GROUP LIMITED (GB) 2014-05-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170281532-A1 2 SUBSTITUTED CEPHEM COMPOUNDS CEP170, CES2, CMBL TP53 2851/4885SRC 4027/4885THRB 4122/4885
US-20150299223-A1 2-SUBSTITUTED CEPHEM COMPOUNDS CEP170, ABL1, CEPT1 TP53 1963/4885SRC 3055/4885THRB 4411/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.